GTMRX
Goldman Sachs Small/Mid Cap Growth Fd Cl R
$17.81
Goldman Sachs Small/Mid Cap Growth Fund Cl R (GTMRX) Holdings
- Holdings Count
- 101
- Total Assets
- 1.18B
- Top 10 Percentage
- 17.77%
Market Cap
Smart Score
Price Target Upside
Analyst Consensus
Yearly Gain
| Name | Market Value | Price & Change | Follow | ||||||
|---|---|---|---|---|---|---|---|---|---|
| MTSIMacom Technology Solutions | 2.14% | $25.16M | ― | $17.30B | 46.99% | Strong Buy | $316.11 | ||
| USD_CASHGOLDMAN SACHS TRUST | 2.03% | $23.87M | ― | ― | ― | ― | ― | ||
| LSCCLattice Semiconductor Corporation | 1.90% | $22.28M | ― | $15.82B | 85.85% | Strong Buy | $163.89 | ||
| ROIVRoivant Sciences Ltd. | 1.78% | $20.89M | ― | $29.84B | 100.24% | Strong Buy | $49.2 | ||
| BTSGBrightSpring Health Services, Inc. | 1.77% | $20.74M | ― | $14.42B | 114.16% | Strong Buy | $84.44 | ||
| CRSCarpenter Technology Corp | 1.69% | $19.85M | ― | $14.73B | -5.50% | Moderate Buy | $474 | ||
| ONTOOnto Innovation | 1.68% | $19.70M | ― | $9.69B | 61.17% | Strong Buy | $337.09 | ||
| SNSharkNinja, Inc. | 1.65% | $19.35M | ― | $31.92B | 146.18% | Strong Buy | $242.25 | ||
| HALOHalozyme Therapeutics | 1.60% | $18.81M | ― | $11.74B | 44.99% | Moderate Buy | $117.71 | ||
| SITMSitime Corporation | 1.54% | $18.07M | ― | $13.43B | 54.10% | Strong Buy | $736.5 |
Sector Breakdown
- Healthcare25.68%
- Technology25.25%
- Industrials21.44%
- Consumer Cyclical11.94%
- General6.00%
- Financial5.80%
- Energy2.38%
- Basic Materials0.77%
- Consumer Defensive0.74%
Countries Breakdown
- United States97.97%
Breakdown By Smart Score
The weighted average smart score of the GTMRX Mutual Fund is 7
- 1013.58%
- 914.89%
- 818.21%
- 717.22%
- 620.53%
- 54.59%
- 46.91%
- 32.87%
- 21.22%
- 10.00%
GTMRX Mutual Funds FAQ
What are Mutual Funds GTMRX’s top 3 holdings?
GTMRX’s top 3 holdings are MTSI, USD_CASH, LSCC.
What is Mutual Funds GTMRX’s holdings count?
Mutual Funds GTMRX’s is holdings 101 different assets.
What are the total assets of Mutual Funds GTMRX?
Mutual Funds GTMRX’s total assets are 1.18B.

